AllQuantitative Report
Argus•February 24, 2021
Argus•February 24, 2021JAZZ: Raising target price to $178.00
Summary
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and indicat
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeActions
Download Full ReportRelated Reports
- Analyst Report: BioMarin Pharmaceutical Inc.Apr 25, 2024 •
BMRN
- Analyst Report: Incyte Corp.Apr 25, 2024 •
INCY
- Market Digest: FCX, FI, INCY, PG, STX, T, OCApr 25, 2024 •
FI, OC, T, STX, PG, INCY, FCX
- EXEL: What does Argus have to say about EXEL?Apr 24, 2024 •
EXEL
- NBIX: Raising target price to $147.00Apr 24, 2024 •
NBIX